What is NDC 71335-3183?

71335-3183 is the product NDC for Levothyroxine Sodium, Levothyroxine sodium 137 ug/1 tablet, listed with the FDA by Bryant Ranch Prepack. It has 5 package NDCs, shown above in 10- and 11-digit form.

Bryant Ranch Prepack, NDC labeler code 71335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Levothyroxine Sodium?

517 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Levothyroxine Sodium NDC 71335-3183

NDC codes

FDA NDC Directory

Product NDC (as listed)71335-3183Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71335-3183Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71335-3183-1	7133531830171335318301	30 TABLET in 1 BOTTLE (71335-3183-1)Marketed from Sep 28, 2026
71335-3183-2	7133531830271335318302	100 TABLET in 1 BOTTLE (71335-3183-2)Marketed from Sep 28, 2026
71335-3183-3	7133531830371335318303	90 TABLET in 1 BOTTLE (71335-3183-3)Marketed from Sep 28, 2026
71335-3183-4	7133531830471335318304	28 TABLET in 1 BOTTLE (71335-3183-4)Marketed from Sep 28, 2026
71335-3183-5	7133531830571335318305	60 TABLET in 1 BOTTLE (71335-3183-5)Marketed from Sep 28, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Levothyroxine Sodium
Generic name (nonproprietary): levothyroxine sodium
Active ingredients: Levothyroxine sodium — 137 ug/1
Dosage form: Tablet
Route: Oral
Labeler: Bryant Ranch PrepackNDC labeler code 71335
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211417
Marketing start: Dec 21, 2022
Listing expires: Dec 31, 2027
Other FDA classes: Thyroxine (Chemical structure)
Identifiers: Product ID 71335-3183_eaa08ef3-9230-4a3d-b00f-7e5a7e9b7fdaSPL ID eaa08ef3-9230-4a3d-b00f-7e5a7e9b7fdaSPL set ID 48a366d8-f5ac-47b0-84e3-f88251def70cRxCUI 966270UNII 9J765S329G
Pharmacologic class: l-Thyroxine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335318301 followed by a unit qualifier and the quantity

Package 71335-3183-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 28, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Hypothyroidism Levothyroxine sodium tablets are indicated in adult and pediatric patients, including neonates, as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression Levothyroxine sodium tablets are indicated in adult and pediatric patients, including neonates, as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer. Limitations of Use Levothyroxine sodium tablets are not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 71335-3183

What is NDC 71335-3183?: 71335-3183 is the product NDC for Levothyroxine Sodium, Levothyroxine sodium 137 ug/1 tablet, listed with the FDA by Bryant Ranch Prepack. It has 5 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Levothyroxine Sodium.
What is the active ingredient?: Levothyroxine sodium.
Who is the labeler?: Bryant Ranch Prepack, NDC labeler code 71335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Levothyroxine Sodium?: 517 other product NDCs are listed under this name. See all Levothyroxine Sodium NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Levothyroxine Sodium NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Levothyroxine Sodium	Levothyroxine sodium .05 mg/1	TabletOral	Coupler LLC	67046-0819	67046-0819-03
Levothyroxine Sodium	Levothyroxine sodium .137 mg/1	TabletOral	Coupler LLC	67046-0972	67046-0972-03
Levothyroxine Sodium	Levothyroxine sodium .2 mg/1	TabletOral	Coupler LLC	67046-0387	67046-0387-03
Levothyroxine Sodium	Levothyroxine sodium .125 mg/1	TabletOral	Coupler LLC	67046-0951	67046-0951-03
Levothyroxine Sodium	Levothyroxine sodium 100 ug/1	TabletOral	Coupler LLC	67046-1679	67046-1679-03
Levothyroxine Sodium	Levothyroxine sodium .175 mg/1	TabletOral	Coupler LLC	67046-0517	67046-0517-03
Levothyroxine Sodium	Levothyroxine sodium .15 mg/1	TabletOral	Coupler LLC	67046-0515	67046-0515-03
Levothyroxine Sodium	Levothyroxine sodium .1 mg/1	TabletOral	Coupler LLC	67046-0569	67046-0569-03
Levothyroxine Sodium	Levothyroxine sodium .075 mg/1	TabletOral	Coupler LLC	67046-0801	67046-0801-03
Levothyroxine Sodium	Levothyroxine sodium .112 mg/1	TabletOral	Coupler LLC	67046-0290	67046-0290-03

All 518 Levothyroxine Sodium NDCs

Other NDCs under ANDA 211417

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211417
Product	Strength	Form · route	Labeler	Product NDC
Levothyroxine Sodium	Levothyroxine sodium 100 ug/1	TabletOral	Coupler LLC	67046-1679
Levothyroxine Sodium	Levothyroxine sodium 88 ug/1	TabletOral	REMEDYREPACK INC.	70518-4434
Levothyroxine Sodium	Levothyroxine sodium 75 ug/1	TabletOral	REMEDYREPACK INC.	70518-4435
Levothyroxine Sodium	Levothyroxine sodium 125 ug/1	TabletOral	REMEDYREPACK INC.	70518-4438
Levothyroxine Sodium	Levothyroxine sodium 100 ug/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-8807
Levothyroxine Sodium	Levothyroxine sodium 75 ug/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-8806
Levothyroxine Sodium	Levothyroxine sodium 175 ug/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-8811
Levothyroxine Sodium	Levothyroxine sodium 75 ug/1	TabletOral	NorthStar RxLLC	72603-662
Levothyroxine Sodium	Levothyroxine sodium 25 ug/1	TabletOral	NorthStar RxLLC	72603-660
Levothyroxine Sodium	Levothyroxine sodium 50 ug/1	TabletOral	NorthStar RxLLC	72603-661
Levothyroxine Sodium	Levothyroxine sodium 125 ug/1	TabletOral	NorthStar RxLLC	72603-666
Levothyroxine Sodium	Levothyroxine sodium 88 ug/1	TabletOral	NorthStar RxLLC	72603-663
Levothyroxine Sodium	Levothyroxine sodium 100 ug/1	TabletOral	NorthStar RxLLC	72603-664
Levothyroxine Sodium	Levothyroxine sodium 112 ug/1	TabletOral	NorthStar RxLLC	72603-665
Levothyroxine Sodium	Levothyroxine sodium 137 ug/1	TabletOral	NorthStar RxLLC	72603-667
Levothyroxine Sodium	Levothyroxine sodium 150 ug/1	TabletOral	NorthStar RxLLC	72603-668
Levothyroxine Sodium	Levothyroxine sodium 175 ug/1	TabletOral	NorthStar RxLLC	72603-669
Levothyroxine Sodium	Levothyroxine sodium 75 ug/1	TabletOral	NuCare Pharmaceuticals, Inc.	68071-3887
Levothyroxine Sodium	Levothyroxine sodium 200 ug/1	TabletOral	NorthStar RxLLC	72603-701
Levothyroxine Sodium	Levothyroxine sodium 50 ug/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-4005

Showing 20 of 40.